Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The bulk of evidence is pre-clinical, concentrated in skin, wound-healing, and hair-follicle research
Forty-two patients treated with six cycles of decitabine showed an overall efficacy of 47.6%, with seven complete remissions (16.6%), eight myelosuppressions (19%), one partial remission (2.4%), and four hematological improvements (9.5%)
Table 2 explores additional studies demonstrating a lower prevalence of dental caries in patients with ASD compared to nonASD populations
Psychiatry 26 , 57025714 (2021)
US$ 25.95
US$ 29.03
US$ 26.87
